MX2015016942A - Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas. - Google Patents

Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas.

Info

Publication number
MX2015016942A
MX2015016942A MX2015016942A MX2015016942A MX2015016942A MX 2015016942 A MX2015016942 A MX 2015016942A MX 2015016942 A MX2015016942 A MX 2015016942A MX 2015016942 A MX2015016942 A MX 2015016942A MX 2015016942 A MX2015016942 A MX 2015016942A
Authority
MX
Mexico
Prior art keywords
acid compound
silicic acid
preparation
pelargonium sidoides
solid
Prior art date
Application number
MX2015016942A
Other languages
English (en)
Inventor
Youn Woong Choi
Byung Gu Min
Sang Min Cho
Do Hyoung Ki
Ji Hyun Ahn
Byung Hoon Lee
Hyung Jun Joon
Won Tae Jung
Kyu Yeol Nam
Dong Gyu Lee
Jin Seong Chung
Original Assignee
Korea United Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53025925&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2015016942(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Korea United Pharm Inc filed Critical Korea United Pharm Inc
Publication of MX2015016942A publication Critical patent/MX2015016942A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con una preparación sólida que incluye un extracto de Pelargonium sidoides y un compuesto de ácido silícico, que se puede formular en una forma sólida mediante adsorción directa del extracto de Pelargonium sidoides sobre un compuesto de ácido silícico, y un método de preparación de la misma. Debido a que la preparación sólida que incluye el extracto de Pelargonium sidoides y el compuesto de ácido silícico de la presente invención tiene mayor estabilidad que una preparación líquida como un jarabe, y no tiene aditivos tales como azúcares, no existe preocupación acerca de una contaminación microbiana o descomposición de la preparación. Además, es posible envasar la preparación sólida individualmente. Debido a que la preparación sólida es menor en volumen que la preparación líquida, es bastante manejable, y también existe una conveniencia de que no son necesarias herramientas adicionales para injerir el fármaco. Además, el ingrediente activo se puede injerir en la cantidad igual cada vez.
MX2015016942A 2013-12-20 2014-12-19 Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas. MX2015016942A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20130159980A KR101497508B1 (ko) 2013-12-20 2013-12-20 펠라고니움 시도이데스 추출물 및 규산 화합물을 포함하는 고형 제제 및 이의 제조 방법
PCT/KR2014/012592 WO2015093899A1 (en) 2013-12-20 2014-12-19 Solid preparations containing pelargonium sidoides extracts and silicic acid compound, and preparing method thereof

Publications (1)

Publication Number Publication Date
MX2015016942A true MX2015016942A (es) 2016-04-25

Family

ID=53025925

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015016942A MX2015016942A (es) 2013-12-20 2014-12-19 Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas.
MX2020003134A MX2020003134A (es) 2013-12-20 2015-12-09 Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2020003134A MX2020003134A (es) 2013-12-20 2015-12-09 Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas.

Country Status (10)

Country Link
US (1) US20160287651A1 (es)
EP (1) EP3082774A4 (es)
KR (1) KR101497508B1 (es)
CN (1) CN105246465B (es)
BR (1) BR112015030090B1 (es)
HK (1) HK1215669A1 (es)
MX (2) MX2015016942A (es)
PH (1) PH12015502499B1 (es)
RU (1) RU2612085C1 (es)
WO (1) WO2015093899A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800002457A1 (it) * 2018-02-07 2019-08-07 Neilos S R L Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie
KR20200004178A (ko) * 2018-07-03 2020-01-13 한국유나이티드제약 주식회사 펠라고니움 시도이데스 추출물을 포함하는 약학 조성물 및 이의 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
KR100210106B1 (ko) * 1997-06-02 1999-07-15 윤종용 냉장고의 급수호스 고정장치
DE102004032439A1 (de) * 2004-07-05 2006-02-02 Iso Arzneimittel Gmbh & Co Kg Verwendung von Extrakten aus Wurzeln von Pelargonium sidoides und Pelargonium reniforme
JPWO2007097333A1 (ja) * 2006-02-20 2009-07-16 アサヒビール株式会社 顆粒、錠剤およびそれらの製造方法
DE102006032326A1 (de) * 2006-07-12 2008-01-17 Dr. Willmar Schwabe Gmbh & Co. Kg Verwendung von Extrakten aus Pelargonium sidoides und/oder Pelargonium reniforme sowie diese Extrakte enthaltende Mittel und pharmazeutische Formulierungen
EP2134369B1 (de) * 2007-04-17 2019-01-02 Dr. Willmar Schwabe GmbH & Co. KG Verfahren zur herstellung von trockenextrakten aus pelargonium sidoides und pelargonium reniforme
EP2178511B1 (en) * 2007-06-22 2011-03-02 Bristol-Myers Squibb Company Tableted compositions containing atazanavir
CN103041768A (zh) * 2013-01-09 2013-04-17 内蒙古科技大学 一种改性硅酸钙吸附剂的制备方法

Also Published As

Publication number Publication date
BR112015030090A2 (pt) 2017-07-25
CN105246465A (zh) 2016-01-13
RU2612085C1 (ru) 2017-03-02
CN105246465B (zh) 2018-01-30
MX2020003134A (es) 2020-07-28
PH12015502499A1 (en) 2016-02-22
US20160287651A1 (en) 2016-10-06
KR101497508B1 (ko) 2015-03-03
BR112015030090B1 (pt) 2023-02-14
PH12015502499B1 (en) 2016-02-22
HK1215669A1 (zh) 2016-09-09
EP3082774A4 (en) 2017-05-10
EP3082774A1 (en) 2016-10-26
WO2015093899A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
AU2017279565B2 (en) RNA formulation for immunotherapy
IL244206A0 (en) A pharmaceutical preparation containing a pyrimidine compound as an active ingredient
MX338515B (es) Derivados de tetrahidroquinolina utiles como inhibidores de bromodominio.
WO2013057013A3 (en) Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
EP3067059A4 (en) Pharmaceutical composition for preventing or treating thyroid diseases, containing lonicera caerulea l. var. edulis fruit extract as active ingredient
MX2014011053A (es) Formulacion concentrada liquida que contiene un insecticida de piripiropeno ii.
MX2021009377A (es) Formulaciones de espuma y aparatos para su suministro.
MX360698B (es) Formulación concentrada líquida que contiene un insecticida de piripiropeno i.
MX362770B (es) Formulación concentrada líquida que contiene un insecticida de piripiropeno iii.
WO2014121764A3 (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
WO2013109388A3 (en) 1,5-naphthyridine derivatives and melk inhibitors containing the same
EP2865664A4 (en) NOVEL COMPOUND HAVING THE ABILITY TO INHIBIT ENZYME 11B-HSD1 OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESS FOR THE PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
WO2011148209A3 (en) Use of diatomaceous earth in the pharmaceutical industry
PH12015502499A1 (en) Solid preparations containing pelargonium sidoides extracts and silicic acid compound, and preparing method thereof
MX357704B (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
EA032913B1 (ru) Препараты производных пиримидиндиона
MX2015004314A (es) Formulacion de aroma y fragancia (iii).
MY170724A (en) Use of certain trioxygenated benzene derivatives in body fat management
MX2014006201A (es) Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse.
WO2011093831A3 (en) Effervescent formulations comprising cefprozil as active agent
MX358798B (es) Formulacion de aroma y fragancia (v).
WO2014150959A3 (en) Method and products for enhancing cellular uptake of drug and dietary supplements
MX360017B (es) Formulación de aroma y fragancia (iv).
GB201107629D0 (en) Hydrophobic preparations

Legal Events

Date Code Title Description
FG Grant or registration